0 results for 'Valeant Pharmaceuticals International, Inc.'
When It Comes To Recovering on Securities Class Actions, More Money Means More Complexity
Please forgive us as we paraphrase the late, great economic philosopher The Notorious B.I.G.
New Prop 65 Lawsuit Filed Against J&J, Others Over Talc's Safety
The lawsuit, filed by Simmons Hanly Conroy, comes six months after the Lanier Law Firm voluntarily dismissed a similar Prop 65 suit against Johnson & Johnson and names more than a dozen defendants, including CVS and Bausch Health.
Report: Investors Targeted Lawsuits at Cannabis Companies in 2019
According to NERA Economic Consulting's annual report, released on Tuesday, six lawsuits alleged securities fraud against cannabis companies. There was only one in 2018.
Investors Targeted Lawsuits at Cannabis Companies in 2019, Report Finds
According to NERA Economic Consulting's annual report, released on Tuesday, six lawsuits alleged securities fraud against cannabis companies. There was only one in 2018.
Robbins Geller and Simpson Thacher Hammer Out $1.2B Valeant Settlement
Plaintiffs alleged the company now known as Bausch Health had "formed a secret network of so-called specialty pharmacies to artificially inflate the sale of Valeant drugs using a variety of fraudulent practices."
Daily Dicta: Robbins Geller; Simpson Thacher Hammer Out $1.2B Valeant Settlement
"Resolving this action enables Bausch Health to close the door on one of the more meaningful and unpredictable liabilities associated with the legacy Valeant era," said the company's CEO.
Edwards v. Sequoia Fund Inc.
Publication Date: 2019-09-13 Practice Area: Securities Litigation
Industry: Investments and Investment Advisory
Court: U.S. Court of Appeals for the Second Circuit Judge: Circuit Judge Denny Chin Attorneys: For plaintiff: For Plaintiffs-Appellants: Alan M. Pollack, on the brief, Felicia S. Ennis, Robinson Brog Leinwand Greene Genovese & Gluck, P.C., New York, New York, and Raymond Farrow and Mark A. Griffin, Keller Rohrback L.L.P., Seattle, Washington, on the brief. For defendant: For Defendant-Appellee: Amy D. Roy and Lee S. Gayer, on the brief, Robert A. Skinner, Ropes & Gray LLP, Boston, Massachusetts, and New York, New York. Case number: 18-3467-cv
SEC's 1998 Guidance Allows Fund's 'Passive Increase' Concentration of Assets in Industry
Second Circuit Affirms Dismissal in Class Action Targeting 'Passive' Concentration of Investments
A three-judge panel of the Second Circuit held that Sequoia's investment policy allowed for "passive" changes in value that propelled the fund's position in the health care industry to exceed the threshold following its initial investment.
Tesla, CBS and United See New General Counsel: February 2019 In-House Moves
A roundup of major in-house moves occurring in February.TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Vaishali Rao, Hinshaw & Culbertson Partner 1 minute read
Resources
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now